Hemanathan Vembuli

Hemanathan Vembuli

Auto-generated profile, based on publicly available information

Hemanathan Vembuli

Indian Council of Medical Research (ICMR) - Department of Virology and Biotechnology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
EDEvangeline Ann Daniel
Evangeline Ann Daniel
BSBalakumaran Sathiyamani
Balakumaran Sathiyamani
KTKannan Thiruvengadam
Kannan Thiruvengadam
SVSandhya Vivekanandan
Sandhya Vivekanandan
HVHemanathan Vembuli
Hemanathan Vembuli
LHLuke Elizabeth Hanna
Luke Elizabeth Hanna
The early diagnosis of tuberculosis with novel non-sputum-based biomarkers is of high priority in End TB strategy. MicroRNAs are significant regulators of TB pathogenesis and their differential expression pattern among healthy, latent, and active TB population has revealed their potentiality as biomarkers in recent studies. We performed systematic review and meta-analysis on the role of host miRNAs in TB diagnosis. PubMed, Ovid, and Cochrane databases were searched to retrieve published literature. Relevant studies were screened, and their quality was assessed using STARD guidelines and QUADAS-2 tool. Heterogeneity of studies and overall pooled results of sensitivity, specificity, and DOR were determined by forest plots. Out of 447 studies, 21 were included for qualitative analysis and eight for meta-analysis. Among these, miR-31 had the maximum diagnostic accuracy, with a sensitivity of 96% (89·7-98·5), specificity of 89% (81·2-93·8), and DOR of 345·9 (90·2-1326·3), meeting the minimal target product profile (TPP) for TB diagnostics. Funding Information: This work was supported by the Department of Science and Technology (DST), DST-INSPIRE fellowship. Declaration of Interests: The authors declare no conflicts of interest.